Related Experiment Video
Updated: Jul 16, 2026
05:26
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
[Perioperative cardioprotection. Golden standard beta-blockade?]
Nils Butte1, B W Böttiger, P Teschendorf
1Klinik für Anaesthesiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Deutschland. nils.butte@med.uni-heidelberg.de
Der Anaesthesist
|March 8, 2007
Summary
Perioperative beta-blockers can reduce heart attack risks in surgical patients. Optimal timing, dosage, and patient selection for beta-blocker therapy require further investigation for enhanced cardiovascular risk management.
Area of Science:
- Cardiology
- Anesthesiology
- Pharmacology
Context:
- Increasing life expectancy leads to a higher prevalence of cardiovascular diseases in surgical patients.
- Myocardial ischemia poses a significant risk for perioperative morbidity and mortality.
Purpose:
- To evaluate interventions for lowering perioperative cardiovascular risk.
- To address optimal timing, dosage, and patient selection for beta-blocker therapy.
- To discuss alternative cardioprotective strategies.
Summary:
- Beta-blockers are a primary intervention for perioperative cardiovascular risk, though optimal use remains debated.
- Statins offer cardioprotection via lipid-lowering and pleiotropic effects.
- Alternative strategies include alpha-2 agonists, thoracic epidural analgesia, and coronary revascularization.
Impact:
- Provides insights into optimizing perioperative beta-blocker use for high-risk surgical patients.
- Highlights the role of statins and other interventions in reducing perioperative cardiac events.
- Informs clinical decision-making for managing cardiovascular risk in the perioperative period.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...